Current Report Filing (8-k)
May 02 2023 - 4:32PM
Edgar (US Regulatory)
0001831874
false
0001831874
2023-04-26
2023-04-26
0001831874
IRAAU:UnitMember
2023-04-26
2023-04-26
0001831874
us-gaap:CommonClassAMember
2023-04-26
2023-04-26
0001831874
us-gaap:WarrantMember
2023-04-26
2023-04-26
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 26, 2023
IRIS ACQUISITION CORP
(Exact name of registrant as specified in its charter)
Delaware |
|
001-40167 |
|
85-3901431 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
3rd Floor Zephyr House
122 Mary Street, George
Town
PO Box 10085
Grand Cayman KY1-1001, Cayman Islands
(Address of principal executive offices, including
zip code)
Registrant’s telephone number,
including area code: 971 4
3966949
(Former name or former address,
if changed since last report)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name of each
exchange on
which registered |
|
|
|
|
|
Units, each consisting of one share of Class A Common Stock and one-fourth of one Redeemable Warrant |
|
IRAAU |
|
The Nasdaq Stock Market LLC |
|
|
|
|
|
Class A Common Stock, par value $0.0001 per share |
|
IRAA |
|
The Nasdaq Stock Market LLC |
|
|
|
|
|
Warrants, each exercisable for one share of Class A Common Stock $11.50 per share |
|
IRAAW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter)
or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company x
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing.
On May 2, 2023, Iris Acquition
Corp (the “Company”) notified the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)
that as a result of the resignation of Shahibhushan Borade (“Dr. Borade”) from the Company’s board of directors (the “Board”)
(as described below in Item 5.02 of this Current Report on Form 8-K), the Company was no longer in compliance with Nasdaq Listing Rule
5605(c)(2)(A), which requires the audit committee of the Board (the “Audit Committee”) to be composed of at least three independent
directors. The Company is evaluating the appropriate composition of its board committees and fully intends to regain compliance with Rule
5605(c)(2)(A) within the applicable cure period.
Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 26, 2023, Dr. Borade,
an Audit Committee member, notified the Company of his intent to resign as a member of the Board effective April 26, 2023. Dr. Borade’s
decision to resign was not the result of any dispute or disagreement with the Company on any matter relating to the Company’s operation,
policies (including accounting or financial policies) or practices.
SIGNATURE
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
IRIS ACQUISITION CORP |
Dated: May 2, 2023 |
|
|
|
|
|
By: |
/s/ Sumit Mehta |
|
|
Name: Sumit Mehta |
|
|
Title: Chief Executive Officer |
Iris Acquisition (NASDAQ:IRAA)
Historical Stock Chart
From Nov 2024 to Dec 2024
Iris Acquisition (NASDAQ:IRAA)
Historical Stock Chart
From Dec 2023 to Dec 2024